The goal of the health resilience system transformation is to ensure the resilience of the health system amid global health threats, which includes the production to distribution of pharmaceuticals and medical devices that are smooth and domestically produced.

In accordance with Presidential Instruction Number 6 of 2016 concerning the Acceleration of the Development of the Pharmaceutical and Medical Device Industry, President Jokowi has instructed 12 Ministries/Institutions, in realizing independence and increasing the competitiveness of the domestic pharmaceutical and medical device industry through accelerating the development of the pharmaceutical and medical device industry.

One of the instructions for the Minister of Health is to encourage the Ministry of Health to change the ecosystem of the domestic medical device industry to become an industry that focuses on developing domestic medical devices.

The Ministry of Health has set priority programs in the development of the domestic medical device industry, including the preparation of regulations for domestically produced medical devices, meeting the needs of the 10 largest medical devices (by value and by volume) of domestic production, downstreaming the results of research / innovation and clinical trials of domestically produced medical devices.

The strategy of medical device independence is carried out by increasing domestic spending on 16 of the 19 largest medical devices by value & volume of domestic production and production of high-tech medical devices (CT Scan, Endoscopy and MRI). Based on this strategy, the direction of medical device development is carried out in accordance with the top 10 medical devices by volume and by value.

In an effort to increase access, independence, and quality of medical devices, it is necessary to build an integrated research and development ecosystem between academia, the private sector and the government. A complete ecosystem can be formed by a strong 3-party partnership, a triple helix between the research world (academics), the private world (business actors) as a party that utilizes research results, and the government that facilitates innovation.

In connection with this, the Directorate General of Pharmaceuticals and Medical Devices through the Directorate of Pharmaceutical and Medical Device Resilience carried out the Facilitation of Downstreaming the Results of Medical Device Research Development Needs of the National Health Program on 9 - 10 February 2023 at the JS Luwansa Hotel, Jakarta.

The activity which was held with the theme "Building Resilience and Independence of Medical Devices through the Development of a Sustainable Ecosystem of Medical Devices" was carried out with the delivery of information from speakers and question and answer discussions. The Director General of Pharmaceuticals and Medical Devices, L. Rizka Andalucia had the opportunity to attend and provide direction at this meeting.

The Director General said that this activity aims to identify problems in realizing a strong and sustainable medical device ecosystem, agree on actions for the formation and strengthening of the medical device ecosystem, evaluate the needs of medical devices used in national health programs, formulate policies for conducting research and innovation in the field of medical devices that are ready to be commercialized / commercialized to meet the needs of national health programs.